{{Link style|time=2015-12-11T09:03:10+00:00}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 401634790
| IUPAC_name = (1α,2β,4β,7β)-<br />7-[(hydroxidi-2-thienylacetyl)oxy]-9,9-dimethyl-<br />3-oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane bromide
| image = Tiotropium.svg
| width = 150
| image2 = Tiotropium-3D-balls.png
| drug_name = Tiotropium

<!--Clinical data-->
| tradename = Spiriva
| MedlinePlus = a604018
| pregnancy_AU = B1
| pregnancy_US =  
| pregnancy_category =  
| legal_AU = S4
| legal_CA =  
| legal_UK = POM
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = Inhalation (oral)

<!--Pharmacokinetic data-->
| bioavailability = 19.5% (inhalation)
| metabolism = [[Hepatic|Hepatic]] 25%<br />([[CYP2D6|CYP2D6]], [[CYP3A4|CYP3A4]])
| elimination_half-life = 5–6 days
| excretion = [[Renal|Renal]]

<!--Identifiers-->
| CAS_number = 136310-93-5
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_supplemental = <br />{{CAS|186691-13-4}} ([[cation|cation]])
| ATC_prefix = R03
| ATC_suffix = BB04
| PubChem = 5487426
| IUPHAR_ligand = 367
| DrugBank = DB01409
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10482095
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = XX112XZP0J
| ChEMBL = 1201307

<!--Chemical data-->
| C=19 | H=22 | Br=1 | N=1 | O=4 | S=2 
| molecular_weight = 472.416 g/mol
| smiles = C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]
| InChI = 1/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17-/m0/s1
| InChIKey = LERNTVKEWCAPOY-MCGYIYAPBV
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LERNTVKEWCAPOY-MCGYIYAPSA-N
}}
{{medical}}

'''噻托溴铵'''（{{lang-en|Tiotropium bromide}}），一种治疗[[慢性阻塞性肺病|慢性阻塞性肺病]]（COPD）的长效（24小时）[[:en:anticholinergic|抗胆碱能]][[支气管扩张药|支气管扩张药]]，[[勃林格殷格翰|勃林格殷格翰]]和[[輝瑞|輝瑞]]共同推出商品名为Spiriva的吸入式胶囊。

[[Category:支气管扩张药|Category:支气管扩张药]]
[[Category:蕈毒碱性受体拮抗剂|Category:蕈毒碱性受体拮抗剂]]
[[Category:噻吩|Category:噻吩]]
[[Category:环氧化合物|Category:环氧化合物]]
[[Category:辉瑞|Category:辉瑞]]